Browsing by Author Horakova, Dana

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)Citation
2016Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routineBarnett, Michael; Ahmed, Rahil Syed; Benedict, Ralph H B; Bergsland, Niels; Dwyer, Michael G.; Gandhi, Sirin; Horakova, Dana; Jakimovski, Dejan; Vaneckova, Manuela; Weinstock-Guttman, Bianca; Zivadinov, Robert; Central Clinical School: Inst. of Clinical NeurosciencesClinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine, Expert Review of Neurotherapeutics, vol.16, 7, 2016,pp 777-793
2015Defining reliable disability outcomes in multiple sclerosisBarnett, Michael; Cutter, Gary; Duquette, P; et al, Various; Girard, Marc; Havrdova, Eva; Horakova, Dana; Izquierdo, Guillermo; Jokubaitis, Vilija; Kalincik, Tomas; Spelman, Vilija; Trojano, Maria; Central Clinical School: Inst. of Clinical NeurosciencesDefining reliable disability outcomes in multiple sclerosis, Brain, vol.138, 11, 2015,pp 3287-3298
2016Defining secondary progressive multiple sclerosisBarnett, Michael; Vucic, Steve; Buzzard, Katherine; et al, Various; Girard, Marc; Havrdova, Eva; Horakova, Dana; Izquierdo, Guillermo; Jokubaitis, Vilija; Lorscheider, Johannes; Spelman, Tim; Trojano, Maria; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead)Defining secondary progressive multiple sclerosis, Brain, vol.139, PT 9, 2016,pp 2395-2405
2016Defining secondary progressive multiple sclerosisBarnett, Michael; Vucic, Steve; Buzzard, Katherine; et al, Various; Girard, Marc; Havrdova, Eva; Horakova, Dana; Izquierdo, Guillermo; Jokubaitis, Vilija; Lorscheider, Johannes; Spelman, Tim; Trojano, Maria; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead)Defining secondary progressive multiple sclerosis, Brain, vol.139, PT 9, 2016,pp 2395-2405
2016The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosisBarnett, Michael; Boz, Cavit; et al, Various; Grand'Maison, Francois; Havrdova, Eva; Horakova, Dana; Izquierdo, Guillermo; Lugaresi, Alessandra; Spelman, Timothy; Trojano, Maria; Warrender-Sparkes, Matthew; Central Clinical School: Inst. of Clinical NeurosciencesThe effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis, Multiple Sclerosis Journal, vol.22, 4, 2016,pp 520-532
2016Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosisBarnett, Michael; Vucic, Steve; Blizzard, Leigh; et al, Various; Havrdova, Eva; Horakova, Dana; Izquierdo, Guillermo; Lugaresi, Alessandra; Shaygannejad, Vahid; Simpson, Steve; Tao, Chunrong; van der Mei, Ingrid; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead)Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis, Journal of Neurology, Neurosurgery and Psychiatry, vol.87, 12, 2016,pp 1343-1349
2016Risk of early relapse following the switch from injectables to oral agents for multiple sclerosisBarnett, Michael; Vucic, Steve; Burke, Therese Valerie; Butzkueven, Helmut; Duquette, P; et al, Various; Grammond, Pierre; Grand' Maison, Francois; Havrdova, Eva; Hodgkinson, Suzanne J; Horakova, Dana; Izquierdo, Guillermo; Mekhael, L; Spelman, Timothy; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead)Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis, European Journal of Neurology, vol.23, 4, 2016,pp 729-776
2016Risk of early relapse following the switch from injectables to oral agents for multiple sclerosisBarnett, Michael; Vucic, Steve; Burke, Therese Valerie; Butzkueven, Helmut; Duquette, P; et al, Various; Grammond, Pierre; Grand' Maison, Francois; Havrdova, Eva; Hodgkinson, Suzanne J; Horakova, Dana; Izquierdo, Guillermo; Mekhael, L; Spelman, Timothy; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead)Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis, European Journal of Neurology, vol.23, 4, 2016,pp 729-776
2015Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosisBarnett, Michael; Alroughani, Raed; Duquette, P; et al, Various; Girard, Marc; Grammond, P; Horakova, Dana; Izquierdo, Guillermo; Jokubaitis, Vilija; Kalincik, Tomas; Lechner-Scott, Jeannette; Lugaresi, Alessandra; Pucci, Eugenio; Rozsa, Csilla; Spelman, Timothy; Trojano, Maria; Central Clinical School: Inst. of Clinical NeurosciencesSwitch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis, Annals of Neurology, vol.77, 3, 2015,pp 425-435
2017Towards personalized therapy for multiple sclerosis: Prediction of individual treatment responseBarnett, Michael; Vucic, Steve; et al, Various; Havrdova, Eva; Horakova, Dana; Izquierdo, Guillermo; Jokubaitis, Vilija; Kalincik, Tomas; Manouchehrinia, Ali; Sobisek, Lukas; Spelman, Timothy; Trojano, Maria; Central Clinical School: Inst. of Clinical Neurosciences; Westmead Clinical School: MedicineTowards personalized therapy for multiple sclerosis: Prediction of individual treatment response, Brain, vol.140, 9, 2017,pp 2426-2443